tiprankstipranks
Appili Therapeutics Nears Acquisition by Aditxt Inc.
Company Announcements

Appili Therapeutics Nears Acquisition by Aditxt Inc.

Story Highlights

Appili Therapeutics Inc Class A (TSE:APLI) has released an update.

Don't Miss our Black Friday Offers:

Appili Therapeutics Inc. is set to hold a special shareholder meeting to vote on the acquisition of the company by Aditxt Inc., where shareholders will receive a combination of cash and Aditxt stock per Appili share. This arrangement, recommended by Appili’s board, offers a significant premium on Appili’s recent trading price and is expected to accelerate the development of Appili’s infectious disease programs through enhanced capital access and commercialization support.

For further insights into TSE:APLI stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Canadian Auto-Generated NewsdeskAppili Therapeutics Moves Forward with Aditxt Acquisition
TipRanks Canadian Auto-Generated NewsdeskAppili Therapeutics Highlights Progress and Shareholder Support
TheFlyAppili Therapeutics reports Q2 EPS (C$0.01) vs. (C$0.01) last year
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App